Inflammatory bowel disease, especially Crohn’s disease and ulcerative colitis, occupy a prominent place in the structure of gastrointestinal disorders, negatively affecting the quality of life of people of working age and is an important cause of loss of earning capacity.
The conventional treatment of inflammatory bowel disease, including anti-inflammatory therapy, antibodies to tumor necrosis factor-alpha, unfortunately, does not always...
Read more